Status:
UNKNOWN
Dyspnea and Idiopathic Pulmonary Fibrosis
Lead Sponsor:
University Hospital, Lille
Collaborating Sponsors:
Santelys Association
Conditions:
Pulmonary Fibrosis
Eligibility:
All Genders
18+ years
Brief Summary
Longitudinal prospective exploratory study on the evolution of dyspnea, in its sensory and affective dimensions, in patients followed for idiopathic pulmonary fibrosis (IPF), between inclusion and a 6...
Detailed Description
Dyspnea is a multidimensional experience involving a sensory component and an affective component. To better understand this symptom in IPF, this study will describe the different component of dyspnea...
Eligibility Criteria
Inclusion
- diagnosis of IPF according to ATS/ERS guidelines
- dyspnea at rest (VAS ≥ 1) or on exertion (mMRC ≥ 1)
Exclusion
- diffuse interstitial lung disease other than IPF
- other significant chronic pathology that may cause dyspnea: chronic obstructive pulmonary disease, asthma, heart failure, anemia, obesity (non-exhaustive list), except for pulmonary hypertension
Key Trial Info
Start Date :
October 22 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04864990
Start Date
October 22 2021
End Date
October 1 2025
Last Update
April 6 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hop Calmette Chu Lille
Lille, France, 59037